Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms

被引:479
作者
Mandelblatt, Jeanne S. [1 ]
Cronin, Kathleen A.
Bailey, Stephanie
Berry, Donald A.
de Koning, Harry J.
Draisma, Gerrit
Huang, Hui
Lee, Sandra J.
Munsell, Mark
Plevritis, Sylvia K.
Ravdin, Peter
Schechter, Clyde B.
Sigal, Bronislava
Stoto, Michael A.
Stout, Natasha K.
van Ravesteyn, Nicolien T.
Venier, John
Zelen, Marvin
Feuer, Eric J.
机构
[1] Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA
关键词
CARCINOMA IN-SITU; BREAST-CANCER MORTALITY; UPPER AGE LIMIT; COST-EFFECTIVENESS; FOLLOW-UP; WOMEN; OLDER; OVERDIAGNOSIS; OVERTREATMENT; PERFORMANCE;
D O I
10.7326/0003-4819-151-10-200911170-00010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Despite trials of mammography and widespread use, optimal screening policy is controversial. Objective: To evaluate U. S. breast cancer screening strategies. Design: 6 models using common data elements. Data Sources: National data on age-specific incidence, competing mortality, mammography characteristics, and treatment effects. Target Population: A contemporary population cohort. Time Horizon: Lifetime. Perspective: Societal. Interventions: 20 screening strategies with varying initiation and cessation ages applied annually or biennially. Outcome Measures: Number of mammograms, reduction in deaths from breast cancer or life-years gained (vs. no screening), false-positive results, unnecessary biopsies, and overdiagnosis. Results of Base-Case Analysis: The 6 models produced consistent rankings of screening strategies. Screening biennially maintained an average of 81% (range across strategies and models, 67% to 99%) of the benefit of annual screening with almost half the number of false-positive results. Screening biennially from ages 50 to 69 years achieved a median 16.5% (range, 15% to 23%) reduction in breast cancer deaths versus no screening. Initiating biennial screening at age 40 years (vs. 50 years) reduced mortality by an additional 3% (range, 1% to 6%), consumed more resources, and yielded more false-positive results. Biennial screening after age 69 years yielded some additional mortality reduction in all models, but overdiagnosis increased most substantially at older ages. Results of Sensitivity Analysis: Varying test sensitivity or treatment patterns did not change conclusions. Limitation: Results do not include morbidity from false-positive results, patient knowledge of earlier diagnosis, or unnecessary treatment. Conclusion: Biennial screening achieves most of the benefit of annual screening with less harm. Decisions about the best strategy depend on program and individual objectives and the weight placed on benefits, harms, and resource considerations.
引用
收藏
页码:738 / W247
页数:15
相关论文
共 50 条
[31]   Benefits and Harms of CT Screening for Lung Cancer A Systematic Review [J].
Bach, Peter B. ;
Mirkin, Joshua N. ;
Oliver, Thomas K. ;
Azzoli, Christopher G. ;
Berry, Donald A. ;
Brawley, Otis W. ;
Byers, Tim ;
Colditz, Graham A. ;
Gould, Michael K. ;
Jett, James R. ;
Sabichi, Anita L. ;
Smith-Bindman, Rebecca ;
Wood, Douglas E. ;
Qaseem, Amir ;
Detterbeck, Frank C. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (22) :2418-2429
[32]   Predictors of Women's Awareness of the Benefits and Harms of Mammography Screening and Associations with Confusion, Ambivalence, and Information Seeking [J].
Shi, Weijia ;
Nagler, Rebekah H. ;
Fowler, Erika Franklin ;
Gollust, Sarah E. .
HEALTH COMMUNICATION, 2021, 36 (03) :303-314
[33]   Benefits and harms of breast cancer screening with mammography in aged 40-49 years: A systematic review [J].
van den Ende, Caroline ;
Oordt-Speets, Anouk M. ;
Vroling, Hilde ;
van Agt, Heleen M. E. .
INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (07) :1295-1306
[34]   Benefits and harms of prostate cancer screening - predictions of the ONCOTYROL prostate cancer outcome and policy model [J].
Muehlberger, Nikolai ;
Boskovic, Kristijan ;
Krahn, Murray D. ;
Bremner, Karen E. ;
Oberaigner, Willi ;
Klocker, Helmut ;
Horninger, Wolfgang ;
Sroczynski, Gaby ;
Siebert, Uwe .
BMC PUBLIC HEALTH, 2017, 17
[35]   Age to Begin and Intervals for Breast Cancer Screening: Balancing Benefits and Harms [J].
Destounis, Stamatia ;
Santacroce, Amanda .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2018, 210 (02) :279-284
[36]   Were Our Estimates of Overdiagnosis With Mammography Screening in the United States "Based on Faulty Science"? [J].
Bleyer, Archie .
ONCOLOGIST, 2014, 19 (02) :113-126
[37]   The Benefits of Early Detection: Evidence From Modern International Mammography Service Screening Programs [J].
Eby, Peter R. ;
Ghate, Sujata ;
Hooley, Regina .
JOURNAL OF BREAST IMAGING, 2022, 4 (04) :346-356
[38]   Evaluation of the benefits, harms and cost-effectiveness of potential alternatives to iFOBT testing for colorectal cancer screening in Australia [J].
Lew, Jie-Bin ;
St John, D. James B. ;
Macrae, Finlay A. ;
Emery, Jon D. ;
Ee, Hooi C. ;
Jenkins, Mark A. ;
He, Emily ;
Grogan, Paul ;
Caruana, Michael ;
Sarfati, Diana ;
Greuter, Marjolein J. E. ;
Coupe, Veerle M. H. ;
Canfell, Karen .
INTERNATIONAL JOURNAL OF CANCER, 2018, 143 (02) :269-282
[39]   Benefits and harms of cervical screening from age 20 years compared with screening from age 25 years [J].
Landy, R. ;
Birke, H. ;
Castanon, A. ;
Sasieni, P. .
BRITISH JOURNAL OF CANCER, 2014, 110 (07) :1841-1846
[40]   Benefits and harms of cervical screening from age 20 years compared with screening from age 25 years [J].
R Landy ;
H Birke ;
A Castanon ;
P Sasieni .
British Journal of Cancer, 2014, 110 :1841-1846